Contemporary drug development requires conducting clinical trials on an international basis. Meeting the needs for supplying the drug product to these trials must be performed in the most time effective manner. Appropriately manufactured, packaged, and labeled trial supplies must be delivered to many sites in many countries which have diverse regulatory requirements. Some ideas for optimizing the procedures for getting the appropriate information, planning, and executing the proper logistics, accommodating varying national cultures, and meeting the technical and compliance needs for the product will be presented.
MinskAWeinstockD.FDA Export Reform and Enhancement Act of 1996: Exporting Unapproved Products for Investigational Use and Exporting Misbranded/Adulterated Approved Products. Food, Drug, Cosmetic Med Device Law Digest. 1998;15(3):94–96.
2.
Amendment to the Annex of Council Directive 75/318/EEC.
3.
DragoonMGConsumer Product Safety Commission (CPSC) Update on Child Resistant Packaging Requirements and Options. Pharma Engineer. 2000;May/June, 88–90.
